Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04644237 |
|---|---|
| Brief Title: | Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) (DESTINY-LUNG02) |
| First Submitted : | November 19, 2020 |
| First Submitted that Met QC Criteria : | November 19, 2020 |
| First Posted : | November 25, 2020 |
| Results First Submitted : | December 22, 2023 |
| Results First Posted with QC Comments : | January 18, 2024 |
| Results First Submitted that Met QC Criteria : | January 26, 2024 |
| Results First Posted : | January 30, 2024 |
| Last Update Submitted that Met QC Criteria : | April 1, 2024 |
| Last Update Posted : | April 3, 2024 |